Acadia Pharmaceuticals | L'Utile Ante Imposte

Pre Tax Profit Cambiamento Data
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Biogen USD 801.7M 231.6M 2023-06
BioMarin Pharmaceutical USD 33.33M 8.34M 2023-12
Bristol-Myers Squibb USD 4.07B 613M 2023-12
Corcept Therapeutics USD 36.81M 424K 2023-12
Cytokinetics USD -136896000 7.47M 2023-12
Eisai JPY 7.37B 20.91B 2023-09
Eli Lilly USD 2.59B 2.27B 2023-12
Incyte USD 319.15M 14.94M 2023-09
Intra Cellular Therapies USD -28131000 3.92M 2023-12
Moderna USD 70M 2.03B 2023-12
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
PTC Therapeutics USD -19493000 147.1M 2023-12
Sarepta Therapeutics USD -33174000 18.59M 2023-09
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



Acadia Pharmaceuticals L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.